Ticagrelor and Cardiogenic shock - a phase IV clinical study of FDA data

Summary:

Cardiogenic shock is reported as a side effect among people who take Ticagrelor (ticagrelor), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Acetylsalicylic Acid, and have Sedation.

The phase IV clinical study analyzes which people have Cardiogenic shock when taking Ticagrelor. It is created by eHealthMe based on reports of 8,473 people who have side effects when taking Ticagrelor from the FDA, and is updated regularly.

What is Ticagrelor?

Ticagrelor has active ingredients of ticagrelor. eHealthMe is studying from 8,499 Ticagrelor users. Check the latest studies of Ticagrelor.

What is Cardiogenic shock?

Cardiogenic shock (inadequate circulation of blood) is found to be associated with 929 drugs and 1,159 conditions by eHealthMe. Check the latest studies of Cardiogenic shock.

On Jul, 05, 2026

8,473 people reported to have side effects when taking Ticagrelor.
Among them, 87 people (1.03%) have Cardiogenic shock.

Could Ticagrelor cause Cardiogenic shock?

Among these 87 people:

How long have people been on Ticagrelor when they have Cardiogenic shock? *

What is the gender of people who have Cardiogenic shock when taking Ticagrelor? *

female: 56.76 %
male: 43.24 %

What is the age of people who have Cardiogenic shock when taking Ticagrelor? *

What are other drugs people take besides Ticagrelor? *

Acetylsalicylic Acid: 27 people, 31.03%
Clopidogrel: 25 people, 28.74%
Simulect: 20 people, 22.99%
Ciclosporin: 18 people, 20.69%
Midazolam: 18 people, 20.69%
Heparin: 17 people, 19.54%
Piperacillin And Tazobactam: 13 people, 14.94%
Aspirin: 10 people, 11.49%
Kengreal: 8 people, 9.20%
Envarsus Xr: 6 people, 6.90%

What are other side effects people have besides Cardiogenic shock? *

Cardiac Arrest: 34 people, 39.08%
Cardiac Failure: 28 people, 32.18%
Coronary Artery Stenosis (narrowing of coronary artery): 21 people, 24.14%
Acute Coronary Syndrome (acute chest pain and other symptoms that happen because the heart does not get blood): 21 people, 24.14%
Haematoma (collection of blood outside the blood vessels): 21 people, 24.14%
Immunosuppressant Drug Level Increased: 20 people, 22.99%
Hypotonia (low muscle tone): 20 people, 22.99%
Pneumonia: 20 people, 22.99%
Electrolyte Imbalance: 20 people, 22.99%
Dyspnea (difficult or laboured breathing): 20 people, 22.99%

What are the existing conditions these people have? *

Sedation: 19 people, 21.84%
C-Reactive Protein Increased: 16 people, 18.39%
Acute Coronary Syndrome (acute chest pain and other symptoms that happen because the heart does not get blood): 12 people, 13.79%
Cardiac Disorder: 11 people, 12.64%
Immune Tolerance Induction: 11 people, 12.64%
Urinary Tract Infection: 8 people, 9.20%
Percutaneous Coronary Intervention: 7 people, 8.05%
Intervertebral Discitis (infection in the intervertebral disc space): 5 people, 5.75%
Heart Attack: 4 people, 4.60%
Myocarditis (inflammation of heart muscle myocardium): 4 people, 4.60%

* Approximation only. Some reports may have incomplete information.

Do you take Ticagrelor and have Cardiogenic shock?

- Check whether Cardiogenic shock is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ticagrelor:

Ticagrelor (8,499 reports)

Browse all side effects of Ticagrelor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cardiogenic shock:

Cardiogenic shock (929 drugs)

Browse all the conditions that are associated with Cardiogenic shock:

Cardiogenic shock (1,159 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ticagrelor (the active ingredients of Ticagrelor) and Ticagrelor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.